News | News By Subject | News by Disease News By Date | Search News

Macular degeneration News Articles

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
Novartis AG (NVS)'s Next-Generation Eye Drug Works With Fewer Injections Than Rivals     6/21/2017
Ophthotech (OPHT) Plunges as Wet AMD Drug Combo Trials With Novartis AG (NVS) Flops in Phase III Studies     12/13/2016
Regeneron (REGN) Bets $315 Million on Ocular Therapeutix (OCUL) for an Upgraded Form of Eylea     10/14/2016
San Diego’s Pfenex (PFNX) Regains Full Rights to PF582 and Announces Phase I/II Results     8/8/2016
Genentech (RHHBY) Partners Up with Novartis AG (NVS) on Ex-U.S. Rights to Wet AMD Candidate Fovista     11/17/2015
Avalanche Biotech (AAVL) Goes Back to Drawing Board, Performs More Preclinical Studies on Eye Drug     8/17/2015
Roche (RHHBY)'s Avastin Not Linked to Higher Risk of Blindness     8/14/2015
Lpath (LPTN) Shares Fall 80%, Will Cut Jobs After Second Drug Flunks Phase II Trial     5/21/2015
Novartis AG (NVS) Accused of "Bullying" Doctors to Drop Trial of Cheaper Drugs     4/6/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Doctors Who Promote More Expensive Eye Drug Are Among The Highest-Paid Genentech (RHHBY) Consultants     12/11/2014
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Roche (RHHBY) Lucentis, Regeneron (REGN) Eylea Continue To Battle It Out In Eye Market     10/16/2014
Advanced Cell Technology Secures $30 Million Financing     7/3/2014

News from Around the Web
Implanted Telescope Helps Patients Overcome Macular Degeneration, VisionCare Reveals     8/26/2016
Broccoli May Help Treating Age-Related Vision Loss, Buck Institute for Age Research Study     7/7/2016
"Bionic Eye" Helps Man See After Decade Of Impaired Vision     7/23/2015
Smartphone Overuse May "Damage" Eyes, Say Opticians     4/1/2014
Compound Found in Rosemary Protects Against Macular Degeneration in Laboratory Model, Sanford-Burnham Medical Research Institute Study     11/28/2012
Compound Found in Rosemary Pprotects Against Macular Degeneration in Laboratory Model, Sanford-Burnham Medical Research Institute Study     11/27/2012
Omega-3 Fatty Acids Ward Off Macular Degeneration, Brigham and Women's Hospital Study     3/18/2011
Fish Oils May Protect Against Age-related Macular Degeneration, Harvard University Study     3/15/2011
Fish Oil May Thwart Advanced AMD, Johns Hopkins University Study     12/3/2010
American Academy of Ophthalmology: Bevacizumab Tops Anti-VEGF Choice in AMD, Duke University Study Finds     10/20/2010
American Academy of Ophthalmology: Retinoid Drug May Slow Dry AMD Progression     10/19/2010
AMD Treatments Don't Increase Risk of Mortality, Duke University Study     10/12/2010
Roche (RHHBY)'s Cancer Drug Could Save Eyesight of Tens of Thousands, Moorfields Eye Hospital Study     6/14/2010
Additional Genes Associated With Age-Related Macular Degeneration Identified At National Eye Institute     4/19/2010
Poor Night Vision May Predict Age-Related Eye Disease, University of Pennsylvania School of Medicine Study     11/14/2008

Press Releases
LSGPA Invests An Additional $500,000 In Maculogix     7/19/2017
BioTime (BTX) To Host Key Opinion Leader Event On The Topic Of Dry AMD In New York City     7/18/2017
Biophytis Selects SGS Life Science Services (SGSN) To Conduct MACA-PK, Clinical Study Of Macuneos In Dry AMD     6/19/2017
BioTime (BTX) Announces New Positive Data From OpRegen Trial In Dry-AMD     5/9/2017
Opthea Receives Positive Feedback From European Regulatory Agencies For The OPT-302 Clinical Program In Wet AMD     3/20/2017
Tyrogenex Completes Patient Enrollment In Its Phase II Trial Of Orally Administered Vorolanib For Wet Age-Related Macular Degeneration     3/9/2017
BioTime (BTX) Release: Additional Data From Company’s OpRegen Clinical Trial in Dry-AMD to be Presented At ARVO 2017     1/19/2017
Lin Bioscience Licenses First-In-Class Therapeutic Program To Treat Dry Aged-Related Macular Degeneration From Columbia University In Collaboration With NIH     1/6/2017
Ophthotech (OPHT) Announces Results From Pivotal Phase 3 Trials Of Fovista In Wet Age-Related Macular Degeneration     12/12/2016
Exonate Closes Successful Funding Round - To Develop Eye Drops Treatment For Wet Age-related Macular Degeneration (Wet AMD)     12/1/2016
Opthea Completes Patient Enrolment In Phase 1/2A Wet AMD Clinical Trial     11/22/2016
Stealth Biotherapeutics Initiates Phase 1 Study Of Elamipretide In Dry Age-Related Macular Degeneration     11/14/2016
FDA Approves Genentech (RHHBY)'s Lucentis Pre-Filled Ranibizumab Syringe     10/17/2016
Regeneron (REGN) Faces Setback as Eylea Combo Drug Flunks Phase II Test     9/30/2016
Ophthotech Corporation (OPHT) Completes Patient Recruitment In Phase 3 Trial Of Fovista Anti-PDGF Therapy In Combination With Eylea Or Avastin In Wet Age-Related Macular Degeneration     6/20/2016

//-->